Homepage cells - microscopy image

GMP-grade iPSCs

Discover what what’s included in our new
Master Cell Bank manufacturing service

Watch video

Product Catalog

An example item from the catalog
Product Catalog
Products for stem cell research
and 3D cell culture

REPROCELL Brands

Brand: Bioserve
  • Extensive biorepository of human tissue samples
  • Network of clinical sites for prospective sample collection
  • Molecular services
Brand: Stemgent
  • RNA reprogramming systems and services
  • Reagents for pluripotent cell culture and differentiation
  • Extensive portfolio of small molecules
Brand: Alvetex
  • 3D cell culture technology creating in vivo-like cell environment
  • Protocols for stem cell, oncology and other tissue research applications
Brand: Biopta
  • Experts in human tissue research services for drug development
  • Predictive safety, efficacy and ADME assays in human and animal tissues

Subscribe to our Newsletter

Receive REPROCELL updates straight to your inbox, including our quarterly newsletter. We'll only send emails we think you'll like, and you can opt out at any time.
Blog

Latest posts

More on the blog
Everything we know about resistance arteries
Everything we know about resistance arteries

Drug Discovery
21 November 2022

4 ways ex vivo models offer Pharma better alternatives to animal testing
4 ways ex vivo models offer Pharma better alternatives to animal testing

Drug Discovery
1 November 2022

Isolating PBMCs from whole blood using density gradient centrifugation
Isolating PBMCs from whole blood using density gradient centrifugation

Clinical Capabilities
19 October 2022

REPROCELL’s Stemgent Brings mRNA Reprogramming to the Clinical Sector
REPROCELL’s Stemgent Brings mRNA Reprogramming to the Clinical Sector

Stem Cells
14 October 2022

Everything we know about the human relaxin peptide family
Everything we know about the human relaxin peptide family

Drug Discovery
28 September 2022

More on the blog
Corporate News

Latest

More corporate news
REPROCELL invests in Histocell, S.L. a Spain-based CDMO

Stem Cells
23 November 2022

Building economic resilience and unleashing productivity through digital innovation

Drug Discovery
9 November 2022

REPROCELL Inc. and JTB Corp. form a business alliance to provide Personal iPS Service to domestic and overseas customers

Clinical Capabilities
13 October 2022

REPROCELL Inc. and CIRM sign MOU for special access to clinical iPSCs

Clinical Capabilities
5 October 2022

REPROCELL and BioBridge Global sign Memorandum of Understanding to accelerate global manufacturing services using clinical iPSCs

Clinical Capabilities
4 October 2022

More corporate news